SEMI.DATA - signals

Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry; Availability

Name: Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry; Availability
Creator: SemiData
License: https://semidata.dev

FDA - 2016-06-10

FDA issued interim guidance for pharmaceutical compounding facilities using bulk drug substances; not relevant to semiconductor supply chain.

Strategic importance	low

Primary source: https://www.federalregister.gov/documents/2016/06/10/2016-13798/interim-policy-on-compounding-using-bulk-drug-substances-under-section-503b-of-the-federal-food-drug

Structured, queryable access via the SemiData API - GET /v1/signals. Free key (100/day) or x402 micropayment, no signup. Get access ->